
Breast cancer is the leading cause of cancer deaths among women zzso The theory of targeting both cancer cells directly and their blood supply has significant therapeutic zzso However, to date, there are few clinically successful single agents that meet these zzso zzso zzso and zzso zzso are potent zzso of proliferation in a range of cancer zzso The work presented here demonstrates the potent in zzso and in zzso effects of these zzso They cause zzso via the intrinsic zzso zzso in both zzso breast cancer cells and zzso zzso Furthermore, they are potent zzso zzso in zzso as shown by their ability to reduce zzso zzso in zzso zzso zzso We have developed a novel, flow zzso based, ex zzso method which shows in cells recovered from zzso tumors treated with zzso and zzso an increase in zzso zzso arrest and zzso The degree of zzso zzso zzso to tumor zzso Further in zzso studies reveal that both zzso and zzso are orally zzso and extremely zzso when compared to clinically tested zzso As these compounds are zzso against breast cancer and zzso cells they have the potential to be zzso dual acting clinical drugs of the zzso 

